Thyrotoxic crisis (thyroid storm) is a life-threatening exacerbation of the hyperthyroid state leading to decompensation of one or more organ systems. Untreated thyroid storm is fatal, and the case fatality rate is still 21-30%. Timely diagnosis is the key to successful management. We report a patient with undiagnosed thyrotoxicosis who was initially treated for acute surgical abdomen.
CASE HISTORY
A woman aged 61 was admitted with vomiting and colicky umbilical pain. For the past month she had had intermittent watery diarrhoea, but never melaena. A year earlier carcinoma of the cervix had been treated by hysterectomy.
She was frail, febrile (39°C) and tachycardic (130 beats/min) but normotensive and fully conscious. There was mild, tender abdominal distension with rebound tenderness in the left iliac fossa. Bowel sounds were sluggish and tenderness was found on rectal examination. Haemoglobin and platelets were normal but neutrophils were raised (20 X 109/L). Plasma electrolytes, creatinine, liver function tests and glucose were normal. Chest and abdominal X-ray were normal. Electrocardiogram revealed sinus tachycardia. No abnormality was found on emergency laparotomy. Her general condition deteriorated over the next four days with one self-limited episode of atrial fibrillation. On gastroscopy there was mild oesophagitis. Blood, urine and stool cultures grew no pathogens. Despite intravenous broad-spectrum antibiotics, temperature peaked to 40°C and heart rate increased to 150 beats/min. On the seventh day of her hospital admission, lid lag and brisk tendon jerks were noted; she had no goitre or bruit. Urgent thyroid function testing revealed thyroxine at 132 nmol/L (normal 60-156) tri-iodothyronine uptake 73 (normal 92-117), and thyroid stimulating hormone suppressed at <0.1 IU/L. Free thyroxine index was high at 181 (normal 65-130), serum globulin 23 g/L (normal 30-45). Thyroid microsomal antibodies were not detected. Thyrotoxic crisis was diagnosed and she received intravenous propranolol 5 mg, then 80 mg twice daily orally, intravenous hydrocortisone 100 mg three times daily and carbimazole 60 mg orally daily. Within 48 h her general condition improved remarkably and hydrocortisone dose was reduced to stop after two weeks. All symptoms settled over five days and she remained afebrile. She gained 4 kg in three weeks and was discharged on day 30 on propranolol and carbimazole; radio-iodine treatment was given five months later. At four year follow-up she was clinically and biochemically euthyroid (on 150 jig thyroxine daily) and in good health. COMMENT The pathogenesis of thyrotoxic crisis is not fully understood. Most studies show no difference in circulating thyroid hormone levels between patients with uncomplicated thyrotoxicosis and those with thyrotoxic crisis'.
Perhaps the speed of rise in hormone level is more important than the absolute level. In various non-thyroid illnesses, inhibition of thyroid hormone binding may cause an increase in circulating free hormone2. Rapid release of preformed hormone may induce thyroid crises when the gland is manipulated during surgery or treated with radioactive iodine. Tissue intolerance to thyroid hormones may be responsible. Noradrenaline and adrenaline levels are normal in thyrotoxic crisis3 but beta-adrenoreceptor density increases at the expense of alpha-receptors4.
The diagnosis of thyrotoxic crisis remains clinical. Hyperthermia, tachycardia and central nervous system dysfunction are present in most patients5. Our patient had all three. Atypical presentation causes delay in diagnosis. Painful abdomen and vomiting have been described5, but the rebound tenderness was the confounding factor precipitating laparotomy in our patient, delaying the correct diagnosis. Normal total circulating thyroid hormone levels have been reported in thyrotoxic crises, but plasma free thyroxine concentration is usually raised6.
In elderly patients thyrotoxicosis tends to present atypically, with features including lethargy, anorexia and heart failure. This case reinforces the case for thyroid stimulating hormone measurement as the initial screening test for thyroid function. It is quick, easy and inexpensive.
Once thyrotoxic crisis is diagnosed, the treatment is to correct the hyperthyroid state, by inhibition of hormone synthesis and conversion of T4 to T3, to block betaadrenoreceptors, to correct disturbances in other organ systems (e.g. cardiac failure) and to treat precipitating factors, if any. Clinical improvement can be expected within 12-24h but full recovery may take weeks. Coma, jaundice and shock indicate a poor outlook.
In conclusion, not all pyrexial patients have an infection and not all patients with thyrotoxicosis, especially elderly, have typical symptoms and signs. Thyrotoxic crisis can occur when total plasma thyroid hormone concentration is Chronic fatigue syndrome (CFS) is characterized by medically unexplained chronic and disabling physical and mental fatiguel. There is growing evidence of organic abnormalities2 but the involvement of psychological factors in its aetiology and chronicity should also be recognized3.
One approach to the complaint assumes it is post-viral in origin with psychiatric and social antecedents4. The sufferer attributes the fatigue and myalgia which persist beyond an initial infectious episode to a continuing viral infection, and interprets them as indicating that activity hinders recovery. A vicious circle is established in which avoidance of activity leads to deconditioning, depression and the perpetuation of symptoms. This view has encouraged the use of cognitive behaviour therapy to increase exercise in graded stages by inducing a more positive attitude towards activity an approach that has met with encouraging results5. Nevertheless, it would seem wrong to attribute CFS entirely to inactivity and sufferers' illness attributions, if only because there are sufferers who are moderately active and working part-time. Such a model also has difficulty explaining why the symptoms fluctuate within a day, or over longer periods. Furthermore, many sufferers strongly believe that exercise, even in a carefully controlled schedule, will make them feel ill and prolong the complaint. They refuse to contemplate any such therapy6.
In view of the controversy over models of CFS and some sufferers' resistance to increased physical effort, it was decided to encourage direct cognitive control of the fatigue and myalgia that form a prominent feature of the syndrome. Importantly, such control should help break the vicious cycle of fatigue, inactivity and depression described by Wessely4. To these ends hypnosis was chosen, primarily because of its success in the control of pain8 and the perception of muscular effort8. Other advantages of hypnosis include the speed with which experiential control can be established. In addition, posthypnotic suggestions can be given for the control of fatigue and myalgia, effective coping, increased wellbeing and regular practice of prescribed techniques. Here I report three cases in which hypnosis was used in the hope of alleviating CFS. CASE I Patient 1, born in 1943, had led an active outdoor life. He became ill in November 1986 with severe muscle and joint pains and complete exhaustion. CFS was diagnosed in 1991. In 1992 he was discharged from hospital after 10 weeks' complete rest without improvement. When we first saw him in 1992 he was in an extremely debilitated state, avoiding light and sound. Despite his reluctance to make any physical or mental effort he could perform mental arithmetic competently for short periods and had high scores on both immediate and delayed tests of visual and verbal memory, but he performed poorly on a test of logical reasoning.
Hypnotic induction involved progressive muscular relaxation with imagery to achieve deepening. He was a good hypnotic subject. The intervention had four components: (1) involve patient and his wife in the process of assessment and recovery; (2) control sensations of fatigue and myalgia; (3) enhance mental activity by imagining enjoyable scenes of activity, both fantasy and remembered; Department of Psychology, Birkbeck College, Malet Street, London WC1 E 7HX, UK
